Cargando…
The Changing Face of Liver Transplantation in the United States: The Effect of HCV Antiviral Eras on Transplantation Trends and Outcomes
BACKGROUND: Hepatitis C virus (HCV) cirrhosis is the leading indication for liver transplantation in the United States, although nonalcoholic steatohepatitis (NASH) is on the rise. Increasingly effective HCV antivirals are available, but their association with diagnosis-specific liver transplantatio...
Autores principales: | Parrish, Nicholas F., Feurer, Irene D., Matsuoka, Lea K., Rega, Scott A., Perri, Roman, Alexopoulos, Sophoclis P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411219/ https://www.ncbi.nlm.nih.gov/pubmed/30882032 http://dx.doi.org/10.1097/TXD.0000000000000866 |
Ejemplares similares
-
Liver Transplantation for Cholangiocarcinoma: Charting a Path With Lessons Learned From Center Experience
por: Ziogas, Ioannis A., et al.
Publicado: (2021) -
“Raising HOPE”: Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era
por: Cotter, Thomas G., et al.
Publicado: (2021) -
Feasibility of Serial Ultrasound Measurements of the Rectus Femoris Muscle Area to Assess Muscle Loss in Patients Awaiting Liver Transplantation in the Intensive Care Unit
por: Pita, Alejandro, et al.
Publicado: (2020) -
Liver Transplantation for Hepatic Adenoma: A UNOS Database Analysis and Systematic Review of the Literature
por: Ziogas, Ioannis A., et al.
Publicado: (2022) -
Liver Transplantation for Budd-Chiari Syndrome in the MELD Era
por: Alqahtani, Saleh A., et al.
Publicado: (2022)